Ziverel for PPI-refractory reflux symptoms: efficacy and mechanisms of action in humans-Reference-Cited by-同舟云学术

Ziverel for PPI-refractory reflux symptoms: efficacy and mechanisms of action in humans

Published:2023-12-13 Issue: Volume: Page:1-6
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Kuipers Thijs¹²,Oude Nijhuis Renske A.B¹²,van den Wijngaard René M.³,Oors Jac M.¹²,Smout André J. P. M.¹²,Bredenoord Albert J.¹²

Affiliation:

1. Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers location University of Amsterdam, Amsterdam, The Netherlands

2. Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands

3. Tytgat Institute for Liver and GI Research, Academic Medical Center, Amsterdam, The Netherlands

Funder

Norgine B.V;this work was suported by Nutricia Research Foundation

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2023.2290457

Reference25 articles.

1. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review

2. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis

3. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease;Sigterman KE;Cochrane Database Syst Rev,2013

4. PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis

5. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Drug Treatment of Refractory Gastroesophageal Reflux Disease;Advances in Clinical Medicine;2024